Neurocrine Biosciences (NBIX) Financial Analysis & Valuation | Quarter Chart

Neurocrine Biosciences (NBIX)

NBIX
Price: $170
Fair Value: 🔒
🔒score
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs i... more
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endo... more
Description Shares
Market Cap$17.09BExchangeNASDAQ
SectorHealthcareIndustryBiotechnology
CountryUSCEOKyle W. Gano
IPO Date1996-05-23CAGR0.19%
Employees1,800Websitewww.neurocrine.com
Div. Yield—Payout Ratio—
Buy Back Yield0.69%Total Yield0.69%
NBIX chart loading...
Fundamentals Technicals
Enterprise Value$14.72BP/E Ratio24.57
Forward P/E13.5PEG Ratio0.01
P/S Ratio5.98P/B Ratio5.44
P/CF Ratio21.46P/FCF Ratio22.31
EPS$6.92EPS Growth 1Y120%
EPS Growth 3Y981.67%EPS Growth 5Y58.29%
Revenue Growth 1Y28.59%Gross Margin0.98%
Operating Margin0.25%Profit Margin0.22%
ROE0.22%ROA0.14%
ROCE0.19%Current Ratio2.93
Quick Ratio2.85Cash Ratio0.32
Debt/Equity0.12Interest Coverage—
Altman Z Score8.61Piotroski Score5

View Neurocrine Biosciences financial charts →